Efficacy and safety of liraglutide versus lixisenatide as add-on to metformin in subjects with type 2 diabetes.
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Liraglutide (Primary) ; Lixisenatide; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LIRA-LIXI
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 16 Jun 2016 Results published in the Diabetes Care
- 16 Sep 2015 According to Novo Nordisk media release, results were presented in an oral presentation at the 51st Annual Meeting of the European Association for the Study of Diabetes.